Biography of James Breitmeyer

Last update: February 21, 2024

Career

James was Board Director at Zogenix, and Director at Otonomy.

James Breitmeyer is currently President and Chief Executive Officer at Oncternal Therapeutics - View - Oncternal Therapeutics org chart

Create your alert
to follow the career of James Breitmeyer.

Education

James Breitmeyer has a Bachelor in Chemistry and Biology from University of California, Santa Cruz and a PhD in Medicine and Immunology from Washington University School of Medicine in St. Louis.

They have also studied at University of California, Santa Cruz :

Find more alumni from University of California, Santa Cruz


The colleagues of James Breitmeyer

Company Colleagues
Industry Colleagues
  • In the Biotechnology industry, James Breitmeyer has 30,192 colleagues in 2,276 companies located in 40 countries. 14,242 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.

Report an error
Update the org chart details of James Breitmeyer.

Get in Touch

Use our Premium/VIP Service to contact James Breitmeyer by email now. Here are a few tips for establishing great contacts.

Send an email
to James Breitmeyer.
With Skype, Call Oncternal Therapeutics at +1 858... and ask for James Breitmeyer.

Share

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.